Reik & Co’s Moderna MRNA Stock Holding History

Reik & Co’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$738K	Hold	3,830	–	–	0.21%	30
2026 Q2	$268K	Buy	+3,830	New	+$198K	0.07%	53
2024 Q4	–	Sell	-4,898	Closed	-$327K	–	57
2024 Q3	$327K	Buy	4,898 +120	+3%	+$11K	0.08%	47
2024 Q2	$567K	Sell	4,778 -2	-0%	-$253	0.15%	37
2024 Q1	$509K	Hold	4,780	–	–	0.13%	40
2023 Q4	$475K	Hold	4,780	–	–	0.13%	39
2023 Q3	$494K	Buy	4,780 +500	+12%	+$55.8K	0.14%	38
2023 Q2	$520K	Hold	4,280	–	–	0.14%	40
2023 Q1	$657K	Sell	4,280 -105	-2%	-$17.3K	0.19%	38
2022 Q4	$788K	Sell	4,385 -650	-13%	-$106K	0.23%	33
2022 Q3	$595K	Buy	5,035 +400	+9%	+$60.7K	0.19%	37
2022 Q2	$662K	Hold	4,635	–	–	0.19%	36
2022 Q1	$798K	Buy	4,635 +1,400	+43%	+$236K	0.2%	37
2021 Q4	$822K	Buy	3,235 +885	+38%	+$259K	0.2%	35
2021 Q3	$904K	Buy	2,350 +350	+18%	+$129K	0.23%	33
2021 Q2	$470K	Hold	2,000	–	–	0.12%	44
2021 Q1	$262K	Buy	+2,000	New	+$290K	0.07%	48

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Reik & Co's MRNA Position: Q3 2026 in Review

Reik & Co held its Moderna (MRNA) position steady in Q3 2026 at 3,830 shares worth $738K. The position accounts for 0.21% of the portfolio, ranked #30.

Reik & Co first reported a position in MRNA in Q1 2021 and has held it in 17 quarters since. The position peaked at $904K in Q3 2021. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

Reik & Co held 3,830 shares of Moderna worth $738K as of Q3 2026.
Reik & Co left its Moderna share count unchanged in Q3 2026.
Moderna made up 0.21% of Reik & Co's portfolio in Q3 2026, its #30 holding.
Reik & Co first reported a position in Moderna in Q1 2021 and has held it in 17 quarters since.
Reik & Co's Moderna position peaked at $904K in Q3 2021.
633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Reik & Co's 13F filing for Q3 2026, filed 27 Oct 2026.